Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis

Vaccine

Volumn 25, Issue 19, 2007, Pages 3781-3791

  KuoLee, Rhonda ^a   Harris, Greg ^a   Conlan, J Wayne ^a   Chen, Wangxue ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Francisella tularensis; Mice; Mucosal infection; Oral immunization

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; LIVE VACCINE; TULAREMIA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL PROLIFERATION; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; FRANCISELLA TULARENSIS; GRAM NEGATIVE INFECTION; IMMUNIZATION; LETHALITY; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SPLEEN CELL; TULAREMIA;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; FEMALE; FRANCISELLA TULARENSIS; HUMANS; IMMUNIZATION; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TULAREMIA; VACCINES, ATTENUATED; VIRULENCE;

EID: 34247109974     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.02.014     Document Type: Article

References (26)

1. Tarnvik A. Nature of protective immunity to Francisella tularensis. Rev Infect Dis 11 3 (1989) 440-451
2. Tarnvik A., and Berglund L. Tularaemia. Eur Respir J 21 2 (2003) 361-373
3. Sjostedt A., and Brenner D.J. Francisella. Bergey's manual of systematic bacteriology (2002), Springer-Verlag, Berlin
4. Saslaw S., Eigelsbach H.T., Prior J.A., Wilson H.E., and Carhart S. Tularemia vaccine study. II. Respiratory challenge. Arch Int Med 107 (1961) 702-714
5. Saslaw S, Eigelsbach HT, Wilson HE, Prior JA, Carhart S. Tularemia vaccine study. I. Intracutaneous challenge. 1961;107:689-701.
6. Dennis D.T., Inglesby T.V., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., et al. Tularemia as a biological weapon: medical and public health management. JAMA 285 21 (2001) 2763-2773
7. Eigelsbach H.T., and Downs C.M. Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig. J Immunol 87 (1961) 415-425
8. Hornick R.B., and Eigelsbach H.T. Aerogenic immunization of man with live tularemia vaccine. Bacteriol Rev 30 3 (1966) 532-538
9. Burke D.S. Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J Infect Dis 135 1 (1977) 55-60
10. Hodge F.A., Leif W.R., and Silverman M.S. Susceptibility to infection with Pasteurella tularensis and the immune response of mice exposed to continuous low dose rate of gamma radiation: NRDL-TR-68-85. Res Dev Tech Rep (1968) 1-28
11. Eigelsbach H.T., Tulis J.J., Overholt E.L., and Griffith W.R. Aerogenic immunization of the monkey and guinea pig with live tularemia vaccine. Proc Soc Exp Biol Med 108 (1961) 732-734
12. Conlan J., Shen H., Webb A., and Perry M. Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen. Vaccine 20 29-30 (2002) 3465
13. Chen W., Shen H., Webb A., KuoLee R., and Conlan J.W. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background. Vaccine 21 (2003) 3690-3700
14. Wu T.H., Hutt J.A., Garrison K.A., Berliba L.S., Zhou Y., and Lyons C.R. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A. Infect Immun 73 5 (2005) 2644-2654
15. Conlan J.W., Shen H., Kuolee R., Zhao X., and Chen W. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma-dependent mechanism. Vaccine 23 19 (2005) 2477-2485
16. Conlan J.W., KuoLee R., Shen H., and Webb A. Different host defences are required to protect mice from primary systemic vs. pulmonary infection with the facultative intracellular bacterial pathogen, Francisella tularensis LVS. Microb Pathog 32 3 (2002) 127-134
17. Brayden D.J. Oral vaccination in man using antigens in particles: current status. Eur J Pharm Sci 14 3 (2001) 183-189
18. Dietrich G., Griot-Wenk M., Metcalfe I.C., Lang A.B., and Viret J.-F. Experience with registered mucosal vaccines. Vaccine 21 7-8 (2003) 678-683
19. Johansson A., Ibrahim A., Goransson I., Eriksson U., Gurycova D., Clarridge III J.E., et al. Evaluation of PCR-based methods for discrimination of Francisella species and subspecies and development of a specific PCR that distinguishes the two major subspecies of Francisella tularensis. J Clin Microbiol 38 11 (2000) 4180-4185
20. Wahid R., Salerno-Goncalves R., Tacket C.O., Levine M.M., and Sztein M.B. Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909. Vaccine 25 8 (2007) 1416-1425
21. Conlan J.W., Chen W., Shen H., Webb A., and KuoLee R. Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies. Microb Pathog 34 5 (2003) 239-248
22. Tulis J.J., Eigelsbach H.T., and Hornick R.B. Oral vaccination against tularemia in the monkeys. Proc Soc Exp Biol Med 132 3 (1969) 893-897
23. Hornick RB, Dawkins AT, Eigelsbach HT, Tulis JJ. Oral tularemia vaccine in man. Antimicrob Agents Chemother-1966. 1967:11-4.
24. Fulop M., Mastroeni P., Green M., and Titball R.W. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. Vaccine 19 31 (2001) 4465-4472
25. Eigelsbach H.T., Tulis J.J., McGavran M.H., and White J.D. Live tularemia vaccine. I. Host-parasite relationship in monkeys vaccinated intracutaneously or aerogenically. J Bacteriol 84 (1964) 1020-1027
26. Green M., Choules G., Rogers D., and Titball R.W. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease. Vaccine 23 20 (2005) 2680-2686